Cell- and Tissue-Based Therapy
-
Subject Areas on Research
- A cord blood monocyte-derived cell therapy product accelerates brain remyelination.
- Apoptotic cell-based therapies for promoting transplantation tolerance.
- Applications of Gene Editing Technologies to Cellular Therapies.
- Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study.
- Autologous Cord Blood Infusions Are Safe and Feasible in Young Children with Autism Spectrum Disorder: Results of a Single-Center Phase I Open-Label Trial.
- Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature.
- Cardiac regeneration.
- Cell therapy for heart failure: the need for a new therapeutic strategy.
- Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012.
- Cell-based gene therapy for repair of critical size defects in the rat fibula.
- Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
- Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
- Current perspectives on the use of ancillary materials for the manufacture of cellular therapies.
- Delivery of Synthetic mRNA Encoding FOXP3 Antigen into Dendritic Cells for Inflammatory Breast Cancer Immunotherapy.
- Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy.
- Do We Need Full Donor Chimerism? How Alloreactive Cell Therapies without Substantial Engraftment Might Treat Hematologic Cancers.
- Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.
- Effect of Ciliary Neurotrophic Factor on Retinal Neurodegeneration in Patients with Macular Telangiectasia Type 2: A Randomized Clinical Trial.
- Efficient intratracheal delivery of airway epithelial cells in mice and pigs.
- Engineering biosynthetic excitable tissues from unexcitable cells for electrophysiological and cell therapy studies.
- Epidermal growth factor receptor and variant III targeted immunotherapy.
- Genome engineering: a new approach to gene therapy for neuromuscular disorders.
- Genome-editing Technologies for Gene and Cell Therapy.
- High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents.
- Human Mesenchymal Stem Cell-Educated Macrophages Are a Distinct High IL-6-Producing Subset that Confer Protection in Graft-versus-Host-Disease and Radiation Injury Models.
- Immunotherapy for Glioblastoma: Adoptive T-cell Strategies.
- Interneurons from embryonic development to cell-based therapy.
- IxCELL-DCM: rejuvenation for cardiac regenerative therapy?
- Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.
- Migration of human dendritic cells after injection in patients with metastatic malignancies.
- Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering.
- Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial.
- Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases.
- Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.
- Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
- Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy.
- Targeting dorsal root ganglia and primary sensory neurons for the treatment of chronic pain.
- The (Translational) Road Less Traveled.
- Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy.